T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Other Liabilities
ÂĄ20.5m
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Other Liabilities
ÂĄ37.4m
CAGR 3-Years
39%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Other Liabilities
ÂĄ91.5m
CAGR 3-Years
117%
CAGR 5-Years
59%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Liabilities
ÂĄ77.7m
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Liabilities
ÂĄ19.6m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Other Liabilities?
Other Liabilities
20.5m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Other Liabilities amounts to 20.5m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-5%

Over the last year, the Other Liabilities growth was 12%. The average annual Other Liabilities growth rates for Tongling Jieya Biologic Technology Co Ltd have been 4% over the past three years , -5% over the past five years .

Back to Top